Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Intranasal Bevacizumab for HHT-Related Epistaxis
Brief Summary: This is a randomized, controlled, double-blind, placebo-controlled trial of intranasal Avastin (bevacizumab) injection versus saline control for control of HHT-related epistaxis when used in conjunction with bipolar electrocautery.